Early-Phase Clinical Trials at Our Dedicated Facility
VILO Research group - Phase I unit
At Vilo Research Group, Inc., we are proud to offer a state-of-the-art Phase 1 clinical trial unit dedicated to advancing medical research and innovation. Our facility is equipped with the latest technology and staffed by a highly skilled team of professionals committed to ensuring the highest standards of safety, compliance, and patient care.
We specialize in early-phase clinical trials, providing essential data to assess the safety, dosage, and pharmacokinetics of new drugs or treatments. With our expertise and world-class infrastructure, we support the development of groundbreaking therapies, helping to bring promising new treatments to market efficiently and responsibly.
Phase I capabilities
Located in Katy, TX, our 2,500 sq. ft. Kingsland Phase I Facility is purpose-built for outpatient and short-stay clinical research.
The facility supports:
- First-in-Human (FIH) studies
- SAD/MAD studies
- Bioavailability and bioequivalence
- PK/PD studies and vaccine immunogenicity
- Drug-drug interaction and food effect studies
Facility Highlights:
- 5 patient rooms with full monitoring capabilities
- CLIA-waived laboratory for real-time sample processing
- Temperature-controlled pharmacy and crash-cart-ready emergency zone
- EDC, eSource, and secure trial data systems.
Address:
3100 Broadway St #104E, Houston, TX 77017
Web Designer
© Copyright 2019 VILO Research Group – All Rights Reserved